Mercer Superannuation Australia will add private equity to its default pension options for the first time, joining a growing number of retirement funds in embracing the strategy to diversify their holdings https://t.co/hCufh2SvbU ...

Reports 17.9% Increase in Adjusted NII Per Share and 0.9% Increase in NAV from Previous Quarter Quarterly ROE of 14.1% Generates LTM ROE of 9.3% and Beats the BDC Industry Average of 7.0% NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- Saratoga Investment Corp. (NYSE: SAR) (“Saratoga Investment” or “the Company”), a business development company (“BDC”), today announced financial results for its fiscal first quarter 2026 ended May 31, 2025. Summary Financial Information The Company’s summarized financial inform ...

How This Chicago Private Equity Firm Scored The Biggest Exit Of 2025 https://t.co/OUxRK29urL ...

Solana treasury firm Upexi's SOL holdings climb above 735,000 as it eyes tokenized equity https://t.co/VksFted5Y9 ...

Harvard's cooked, Jason. Harvard's cooked. Explain. It turns out, and there's been a lot of people that's posted about this on X, but there continues to be rampant Title 9 violations with respect to admissions. I think Creme Nick, you can probably find it. I think he published one that Colombia was continuing to discriminate against Asian students. Harvard's original case was against Asian students. There was a bunch of woke stuff at other Ivy League schools like UPUPEN. There's all this rampant anti-semiti ...

BOSTON and TORONTO, July 8, 2025 /PRNewswire/ - Manulife Investment Management (Manulife IM) has announced the final close of Manulife Co-Investment Partners III, L.P. and related strategic commitments, raising $1.1 billion—well above its $750 million target and exceeding its 2021 predecessor fund by more than $300 million.This milestone reflects the continued successful fundraising of Manulife IM's co-investment strategy, which is built on the firm's long-standing primary funds platform and deep relationsh ...

- So what do you do to kind of keep yourself sane. - Well, recreation like this. Although I'm not sure that golf is the solution to the insane, sometimes it feels like it is insane.There you go. - Ah, there we are. Over the years I've interviewed the biggest names in finance and they've mostly been men, but things are changing.More and more. I'm meeting powerful women, controlling vast amounts of capital. What did it take for these women to break through and is Wall Street changing now that they have.We are ...

Core Insights - NeOnc Technologies Holdings, Inc. has signed a non-binding term sheet with Quazar Investment to establish a new investment and clinical platform in the MENA region [1][2] - The partnership aims to leverage the UAE's clinical trial infrastructure to advance NeOnc's late-stage drug candidates [3][7] Investment and Structure - The term sheet outlines the formation of NuroMENA Holdings Ltd, which will oversee the establishment of NuroCure, an Abu Dhabi-based subsidiary responsible for clinical trials [2][5] - A proposed equity investment of $50 million is contingent upon NeOnc meeting specific conditions within 120 days [4][8] Clinical Development - NuroCure will initiate clinical trials for NEO100 and NEO212, targeting aggressive brain cancers such as Diffuse Intrinsic Pontine Glioma and glioblastoma multiforme [7][9] - The partnership is positioned to enhance NeOnc's clinical programs through collaboration with Cleveland Clinic Abu Dhabi [3][10] Financial Strategy - Quazar will lead a capital formation round of up to $50 million, with 70% allocated for acquiring NeOnc common stock and 30% for clinical trial and infrastructure development [8][10] - The investment strategy includes executing a Sub-License Agreement for NEO100 and NEO212, facilitating clinical efforts in the region [5][11] Company Background - NeOnc Technologies is focused on developing therapeutics for central nervous system cancers, with a robust patent portfolio extending to 2038 [11] - The company's drug candidates, NEO100 and NEO212, are currently in Phase II clinical trials under FDA Fast-Track status [11]

>> NEWLY, NEWLY RELEASED DATA SHOWS THAT YOUNG WOMEN ARE WORKING AT NEARLY RECORD RATES. A STUDY FROM THE HAMILTON PROJECT LOOKED AT WORKFORCE PARTICIPATION OF SO-CALLED PRIME AGE MEN AND WOMEN. AND THAT RESEARCH FOUND YOUNG WOMEN NOW ARE ARE MORE LIKELY TO WORK THAN THE SAME AGE GROUP YEARS AGO.NEARLY 78% OF WOMEN IN THEIR 20S AND 30S ARE WORKING. INTERESTINGLY, THE OPPOSITE IS TRUE FOR MEN. THE STUDY FOUND THAT A SMALL BUT GROWING SHARE OF PRIME AGE MEN ARE ACTUALLY TAKING ON MORE OF THE CAREGIVING WORK A ...

RT s4mmy (@S4mmyEth)In a sea of red there are two standout tokens this week.The common theme is that they are pushing the boundaries of what's possible within their respective market segments.i) @RektguyAI - The Rekt Litepaper has been published.If there is anything you take away from this, it's the points made around "Liquid Brand Equity" (LBE).I spent more than a decade auditing, performing DD and advising Private and Public companies; "LBE" is an extremely novel concept, and I could see it being adopted ...